A novel GSN variant outside the G2 calcium-binding domain associated with Amyloidosis of the Finnish type.

Amyloidosis of the Finnish type Finnish Amyloidosis Meretoja syndrome gelsolin inherited corneal dystrophy type II lattice dystrophy

Journal

Human mutation
ISSN: 1098-1004
Titre abrégé: Hum Mutat
Pays: United States
ID NLM: 9215429

Informations de publication

Date de publication:
07 2021
Historique:
revised: 15 04 2021
received: 20 01 2021
accepted: 26 04 2021
pubmed: 12 5 2021
medline: 1 4 2022
entrez: 11 5 2021
Statut: ppublish

Résumé

Gelsolin (GSN) variants have been implicated in amyloidosis of the Finnish type. This case series reports a novel GSN:c.1477T>C,p.(Trp493Arg) variant in a family with ocular and systemic features consistent with Finnish Amyloidosis. Exome sequencing performed on affected individuals from two families manifesting cutis laxa and polymorphic corneal stromal opacities demonstrated the classic GSN:c.654G>A,p.Asp214Asn variant in single affected individual from one family, and a previously undocumented GSN:c.1477T>C variant in three affected first-degree relatives from a separate family. Immunohistochemical studies on corneal tissue from a proband with the c.1477T>C variant identified gelsolin protein within histologically defined corneal amyloid deposits. This study reports a novel association between the predicted pathogenic GSN:c.1477T>C variant and amyloidosis of the Finnish type, and is the first to provide functional evidence of a pathological GSN variant at a locus distant to the critical G2 calcium-binding region, resulting in the phenotype of amyloidosis of the Finnish type.

Identifiants

pubmed: 33973672
doi: 10.1002/humu.24214
doi:

Substances chimiques

Gelsolin 0
Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

818-826

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Ardalan, M. R. , Shoja, M. M. , & Kiuru-Enari, S. (2007). Amyloidosis-related nephrotic syndrome due to a G654A gelsolin mutation: the first report from the Middle East. Nephrology, Dialysis, Transplantation, 22(1), 272-275.
Cabral-Macias, J. , Garcia-Montaño, L. A. , Pérezpeña-Díazconti, M. , Aguilar, M.-C. , Garcia, G. , Vencedor-Meraz, C. I. , Graue-Hernandez, E. O. , Chacón-Camacho, O. F. , & Zenteno, J. C. (2020). Clinical, histopathological, and in silico pathogenicity analyses in a pedigree with familial amyloidosis of the Finnish type (Meretoja syndrome) caused by a novel gelsolin mutation. Molecular Vision, 26, 345-354.
Chapelle, A. , de la Chapelle, A. , Tolvanen, R. , Boysen, G. , Santavy, J. , Bleeker-Wagemakers, L. , Maury, C. P. J. , & Kere, J. (1992). Gelsolin-derived familial amyloidosis caused by asparagine or tyrosine substitution for aspartic acid at residue 187. In Nature Genetics, 2(Issue 2), 157-160. https://doi.org/10.1038/ng1092-157
Chen, C.-D. (2001). Furin initiates gelsolin familial amyloidosis in the Golgi through a defect in Ca2 stabilization. In The EMBO Journal, 20(Issue 22), 6277-6287. https://doi.org/10.1093/emboj/20.22.6277
Conceição, I. , Sales-Luis, M. L. , De Carvalho, M. , Evangelista, T. , Fernandes, R. , Paunio, T. , Kangas, H. , Coutinho, P. , Neves, C. , & Saraiva, M. J. (2003). Gelsolin-related familial amyloidosis, Finnish type, in a Portuguese family: Clinical and neurophysiological studies. Muscle & Nerve, 28(6), 715-721.
Efebera, Y. A. , Sturm, A. , Baack, E. C. , Hofmeister, C. C. , Satoskar, A. , Nadasdy, T. , Nadasdy, G. , Benson, D. M. , Gillmore, J. D. , Hawkins, P. N. , & Rowczenio, D. (2014). Novel gelsolin variant as the cause of nephrotic syndrome and renal amyloidosis in a large kindred. Amyloid, 21(Issue 2), 110-112. https://doi.org/10.3109/13506129.2014.891502
Feng, X. , Zhu, H. , Zhao, T. , Hou, Y. , & Liu, J. (2018). A new heterozygous G duplicate in exon1 (c.100dupG) of gelsolin gene causes Finnish gelsolin amyloidosis in a Chinese family. Brain and Behavior, 8(Issue 12):e01151. https://doi.org/10.1002/brb3.1151
Gorevic, P. D. , Munoz, P. C. , Gorgone, G. , Purcell, J. J., Jr. , Rodrigues, M. , Ghiso, J. , Levy, E. , Haltia, M. , & Frangione, B. (1991). Amyloidosis due to a mutation of the gelsolin gene in an American family with lattice corneal dystrophy type II. The New England Journal of Medicine, 325(25), 1780-1785.
Guimera, R. V. (2012). Bcbio-Nextgen: Automated, distributed next-gen sequencing pipeline. EMBnet.journal, 17(Issue B), 30. https://doi.org/10.14806/ej.17.b.286
Haltia, M. , Levy, E. , Meretoja, J. , Fernandez-Madrid, I. , Koivunen, O. , & Frangione, B. (1992). Gelsolin gene mutation-at codon 187-in familial amyloidosis, Finnish: DNA-diagnostic assay. American Journal of Medical Genetics, 42(Issue 3), 357-359. https://doi.org/10.1002/ajmg.1320420321
Huff, M. E. , Page, L. J. , Balch, W. E. , & Kelly, J. W. (2003). Gelsolin domain 2 Ca2+ affinity determines susceptibility to furin proteolysis and familial amyloidosis of Finnish type. Journal of Molecular Biology, 334(1), 119-127.
Kazmirski, S. L. , Isaacson, R. L. , An, C. , Buckle, A. , Johnson, C. M. , Daggett, V. , & Fersht, A. R. (2002). Loss of a metal-binding site in gelsolin leads to familial amyloidosis-Finnish type. Nature Structural Biology, 9(2), 112-116.
Kivelä, T. , Tarkkanen, A. , McLean, I. , Ghiso, J. , Frangione, B. , & Haltia, M. (1993). Immunohistochemical analysis of lattice corneal dystrophies types I and II. The British Journal of Ophthalmology, 77(12), 799-804.
Loeffler, K. U. , Edward, D. P. , & Tso, M. O. (1992). An immunohistochemical study of gelsolin immunoreactivity in corneal amyloidosis. American Journal of Ophthalmology, 113(5), 546-554.
Maury, C. P. (1993). Homozygous familial amyloidosis, Finnish type: Demonstration of glomerular gelsolin-derived amyloid and non-amyloid tubular gelsolin. Clinical Nephrology, 40(1), 53-56.
Maury, C. P. , Kere, J. , Tolvanen, R. , & de la Chapelle, A. (1990). Finnish hereditary amyloidosis is caused by a single nucleotide substitution in the gelsolin gene. FEBS Letters, 276(1-2), 75-77.
McLaren, W. , Gil, L. , Hunt, S. E. , Riat, H. S. , Ritchie, G. R. S. , Thormann, A. , Flicek, P. , & Cunningham, F. (2016). The Ensembl variant effect predictor. Genome Biology, 17(1), 122.
Meretoja, J. (1969). Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms. A previously unrecognized heritable syndrome. Annals of Clinical Research, 1(4), 314-324.
Meretoja, J. (1973). Genetic aspects of familial amyloidosis with corneal lattice dystrophy and cranial neuropathy. Clinical Genetics, 4(3), 173-185.
Nag, S. , Larsson, M. , Robinson, R. C. , & Burtnick, L. D. (2013). Gelsolin: The tail of a molecular gymnast. Cytoskeleton, 70(7), 360-384.
Nag, S. , Ma, Q. , Wang, H. , Chumnarnsilpa, S. , Lee, W. L. , Larsson, M. , Kannan, B. , Hernandez-Valladares, M. , Burtnick, L. D. , & Robinson, R. C. (2009). Ca2 binding by domain 2 plays a critical role in the activation and stabilization of gelsolin. Proceedings of the National Academy of Sciences of the United States of America, 106(Issue 33), 13713-13718. https://doi.org/10.1073/pnas.0812374106
Nikoskinen, T. , Schmidt, E.-K. , Strbian, D. , Kiuru-Enari, S. , & Atula, S. (2015). Natural course of Finnish gelsolin amyloidosis. Annals of Medicine, 47(6), 506-511.
Oregel, K. Z. , Shouse, G. P. , Oster, C. , Martinez, F. , Wang, J. , Rosenzweig, M. , Deisch, J. K. , Chen, C.-S. , & Nagaraj, G. (2018). Atypical presentation of gelsolin amyloidosis in a man of African descent with a novel mutation in the gelsolin gene. American Journal of Case Reports, 19, 374-381. https://doi.org/10.12659/ajcr.907550
Page, L. J. , Suk, J. Y. , Huff, M. E. , Lim, H.-J. , Venable, J. , Yates, J. , Kelly, J. W. , & Balch, W. E. (2005). Metalloendoprotease cleavage triggers gelsolin amyloidogenesis. The EMBO Journal, 24(23), 4124-4132.
Paila, U. , Chapman, B. A. , Kirchner, R. , & Quinlan, A. R. (2013). GEMINI: Integrative exploration of genetic variation and genome annotations. PLoS Computational Biology, 9(7), e1003153.
Rosenberg, M. E. , Tervo, T. M. , Gallar, J. , Acosta, M. C. , Müller, L. J. , Moilanen, J. A. , Tarkkanen, A. H. , & Vesaluoma, M. H. (2001). Corneal morphology and sensitivity in lattice dystrophy type II (familial amyloidosis, Finnish type). Investigative Ophthalmology & Visual Science, 42(3), 634-641.
Schmidt, E.-K. , Atula, S. , Tanskanen, M. , Nikoskinen, T. , Notkola, I.-L. , & Kiuru-Enari, S. (2016). Causes of death and life span in Finnish gelsolin amyloidosis. Annals of Medicine, 48(5), 352-358.
Schmidt, E.-K. , Mustonen, T. , Kiuru-Enari, S. , Kivelä, T. T. , & Atula, S. (2020). Finnish gelsolin amyloidosis causes significant disease burden but does not affect survival: FIN-GAR phase II study. Orphanet Journal of Rare Diseases, 15(Issue 1). https://doi.org/10.1186/s13023-020-1300-5
Sethi, S. , Theis, J. D. , Quint, P. , Maierhofer, W. , Kurtin, P. J. , Dogan, A. , Highsmith, E. W., Jr. (2013). Renal amyloidosis associated with a novel sequence variant of gelsolin. American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation, 61(1), 161-166.
Siggs, O. M. , Souzeau, E. , & Craig, J. E. (2019). Loss of ciliary zonule protein hydroxylation and lens stability as a predicted consequence of biallelic ASPH variation. Ophthalmic Genetics, 40(1), 12-16.
Siggs, O. M. , Souzeau, E. , Taranath, D. A. , Dubowsky, A. , Chappell, A. , Zhou, T. , Javadiyan, S. , Nicholl, J. , Kearns, L. S. , Staffieri, S. E. , Narita, A. , Smith, J. E. H. , Pater, J. , Hewitt, A. W. , Ruddle, J. B. , Elder, J. E. , Mackey, D. A. , Burdon, K. P. , & Craig, J. E. (2020). Biallelic CPAMD8 variants are a frequent cause of childhood and juvenile open-angle glaucoma. Ophthalmology, 127(6), 758-766.
Solomon, J. P. , Page, L. J. , Balch, W. E. , & Kelly, J. W. (2012). Gelsolin amyloidosis: Genetics, biochemistry, pathology and possible strategies for therapeutic intervention. Critical Reviews in Biochemistry and Molecular Biology, 47(3), 282-296.
Solomon, J. P. , Yonemoto, I. T. , Murray, A. N. , Price, J. L. , Powers, E. T. , Balch, W. E. , & Kelly, J. W. (2009). The 8 and 5 kDa fragments of plasma gelsolin form amyloid fibrils by a nucleated polymerization mechanism, while the 68 kDa fragment is not amyloidogenic. Biochemistry, 48(Issue 48), 11370-11380. https://doi.org/10.1021/bi901368e
Sridharan, M. , Edward Highsmith, W. , Kurtin, P. J. , Zimmermann, M. T. , Theis, J. D. , Dasari, S. , & Dingli, D. (2018). A patient with hereditary ATTR and a novel AGel p.Ala578Pro amyloidosis. Mayo Clinic Proceedings, 93(Issue 11), 1678-1682. https://doi.org/10.1016/j.mayocp.2018.06.016
Taira, M. , Ishiura, H. , Mitsui, J. , Takahashi, Y. , Hayashi, T. , Shimizu, J. , Matsukawa, T. , Saito, N. , Okada, K. , Tsuji, S. , Sawamura, H. , Amano, S. , Goto, J. , & Tsuji, S. (2012). Clinical features and haplotype analysis of newly identified Japanese patients with gelsolin-related familial amyloidosis of Finnish type. Neurogenetics, 13(3), 237-243.
Thomsitt, J. , & Bron, A. J. (1975). Polymorphic stromal dystrophy. The British Journal of Ophthalmology, 59(3), 125-132.
Weiss, J. S. , Møller, H. U. , Aldave, A. J. , Seitz, B. , Bredrup, C. , Kivelä, T. , Munier, F. L. , Rapuano, C. J. , Nischal, K. K. , Kim, E. K. , Sutphin, J. , Busin, M. , Labbé, A. , Kenyon, K. R. , Kinoshita, S. , & Lisch, W. (2015). IC3D classification of corneal dystrophies-edition 2. Cornea, 34(2), 117-159.
Zapun, A. , Grammatyka, S. , Déral, G. , & Vernet, T. (2000). Calcium-dependent conformational stability of modules 1 and 2 of human gelsolin. Biochemical Journal, 350(Pt 3), 873-881.
Zorgati, H. , Larsson, M. , Ren, W. , Sim, A. Y. L. , Gettemans, J. , Grimes, J. M. , Li, W. , & Robinson, R. C. (2019). The role of gelsolin domain 3 in familial amyloidosis (Finnish type). Proceedings of the National Academy of Sciences of the United States of America, 116(28), 13958-13963.

Auteurs

Sean Mullany (S)

Flinders Department of Ophthalmology, College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.

Emmanuelle Souzeau (E)

Flinders Department of Ophthalmology, College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.

Sonja Klebe (S)

Department of Pathology, College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.
Department of Anatomical Pathology, SA Pathology, Flinders Medical Centre, Bedford Park, South Australia, Australia.

Tiger Zhou (T)

Flinders Department of Ophthalmology, College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.

Lachlan S W Knight (LSW)

Flinders Department of Ophthalmology, College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.

Ayub Qassim (A)

Flinders Department of Ophthalmology, College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.

Ella C Berry (EC)

Flinders Department of Ophthalmology, College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.

Henry Marshall (H)

Flinders Department of Ophthalmology, College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.

Matthew Hussey (M)

Department of Anatomical Pathology, SA Pathology, Flinders Medical Centre, Bedford Park, South Australia, Australia.

Andrew Dubowsky (A)

Department of Anatomical Pathology, SA Pathology, Flinders Medical Centre, Bedford Park, South Australia, Australia.

James Breen (J)

SAHMRI Bioinformatics Core, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.

Mark M Hassall (MM)

Flinders Department of Ophthalmology, College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.

Richard A Mills (RA)

Flinders Department of Ophthalmology, College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.

Jamie E Craig (JE)

Flinders Department of Ophthalmology, College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.

Owen M Siggs (OM)

Flinders Department of Ophthalmology, College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH